The initiation of a drug discovery journey is a high stake endeavour. The best path to your success is to start with a trustworthy partner that will provide you with crucial, knowledge-based information in the most efficient and timely manner. IniXium is a privately owned contract research organisation (CRO) operating in a pure service mode to serve the drug discovery community. Our dedicated protein experts offer a broad range of services in protein crystallography and biophysics to support the drug discovery efforts of any drug hunter on the planet.
In these difficult times where our industry is needed the most, inixium remains focused on its mission by continuing to provide uninterrupted services to its customers while ensuring the health and safety of our team
Stakes are high, aim for excellence
“From the very beginning, researchers at IniXium pursued multiple creative approaches to solve the technical challenges of our project. These results enabled clinical studies which are on-going. Great team!"Deborah Nicoll-Griffith, Ph.D.President - EndoParagon Inc.
"IniXium has come through on some difficult crystallography projects. They succeed where others struggle."Byron DeLaBarre, Ph.D. President - The Consulting Biochemist
It is with great pleasure that I recommend IniXium as a reliable partner for drug discovery. We at Berg, initiated a hit finding campaign for a protein target that was considered to be challenging to drug. Using their fragment screening services, the IniXium team was able to rapidly provide the much needed confirmed hits for the initiation of the program. The program is currently entering IND enabling studies. Scientists at IniXium were very thorough and thoughtful about interpretation of data and were very adaptable to the needs of the program. Being the Program Champion, I have directly interfaced with the IniXium team and would recommend their services.Vivek K Vishnudas, Ph.D.SVP Drug Discovery & Platform Sciences
“We approached Inixium in hopes of using their mammalian protein expression expertise to produce, at scale, a protein complex for crystallography and biophysical studies. We had tried this project with a number of alternative vendors with limited success. The team at Inixium proved to be great collaborators sharing progress throughout the project. Ultimately, they delivered and allowed us to solve numerous crystal structures of the complex and support our medicinal chemistry efforts.”Joe Patel, Ph.D.Director of Biochemistry, Biophysics & Crystallography - C4 Therapeutics, Inc.
"IniXium is part of Greater Montreal’s network of high end drug discovery service providers with whom NuChem Therapeutics has been collaborating for several years for their protein crystallography expertise. It is always a great pleasure to work with them for their flexibility and adaptability, the high quality protein they systematically deliver for our biochemical assays, and their expert crystallography services for particularly challenging targets. We highly recommend their services as we foresee working with them on a regular basis to complement our portfolio of valued specialized service provider."Marc Janes, Ph.D.Vice President, Business Development, and Innovation - NuChem Therapeutics, Inc.
Relay Therapeutics has a close collaboration with IniXium since 2016. Over the past 4 years, IniXium’ Team has provided crystallography grade proteins from E. coli expression and expert crystallography support for several projects. Our projects with IniXium started with literature protocols that required further optimization and trouble shooting. IniXium was able to quickly optimize expression and purification protocols and provided high quality proteins. We have successfully used IniXium’s milestone model for protein production and to establish crystallization systems. In addition, we are using their FTE support as an extension of our lab for soaking and co-crystallization. They bring an exceptional level of expertise and understanding for small molecule drug discovery timelines which makes it easy to collaborate and communicate. We enjoy working with their team and can highly recommend their services.Christian Klammt, Ph.D. Director Biomolecular Discovery